Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage

Glaucoma etiology often includes retinal ganglion cell (RGC) death associated with elevated intraocular pressure (IOP). However, even when IOP is managed well, disease can progress. It is thus important to develop therapeutic approaches that directly protect RGCs in an IOP-independent manner. Compro...

Full description

Bibliographic Details

Published in:	Pharmaceutics
Main Authors:	Xian Zhang, Nan Zhang, Micah A. Chrenek, Preston E. Girardot, Jiaxing Wang, Jana T. Sellers, Eldon E. Geisert, Charles Brenner, John M. Nickerson, Jeffrey H. Boatright, Ying Li
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Subjects:	nicotinamide riboside retinal ganglion cell neuroprotection microbead optic nerve crush ERG
Online Access:	https://www.mdpi.com/1999-4923/13/6/893